Line 85: | Line 85: | ||
</div> | </div> | ||
<div class='textbody'> | <div class='textbody'> | ||
+ | <div class='grid-container'> | ||
<div class='large-block'> | <div class='large-block'> | ||
<a href='https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement'> | <a href='https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement'> | ||
Line 93: | Line 94: | ||
</a> | </a> | ||
+ | |||
</div> | </div> | ||
</div> | </div> | ||
</div> | </div> | ||
− | |||
<div class='textbody'> | <div class='textbody'> | ||
<div class='grid-container'> | <div class='grid-container'> |
Revision as of 23:56, 16 October 2018
Protein scaffolds for star-shaped antimicrobial peptides
Antibiotic overuse in livestock industry is one of the major drivers to the antibiotic resistance evolution; motivating calls to reduce, replace, and re-think the antibiotic usage in animals. Antimicrobial peptides (AMPs) are a promising alternative to conventional antibiotics. Recently, a class of chemically-synthesized, star-shaped AMPs has been shown to exhibit broad-spectrum antimicrobial activity while maintaining biocompatibility with mammalian cells. In this project, we combinatorially fused a set of known AMPs to structurally diverse, self-assembling protein cores to produce star-shaped complexes. Over 200 fusions were designed and expressed in a cell-free system, then screened for activity, biocompatibility, and membrane selectivity. In addition, we selected 4 AMPs for rational mutagenesis (~12000 variants), and a subset of fusions for molecular dynamic modeling, to identify features of surface charge and star geometry that impact AMP performance. Overall, we aim to create a novel class of selective, non-toxic AMPs which are biologically-produced.